Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an in vivo and in vitro study

Drug Metabolism and Disposition

Volumn 33, Issue 7, 2005, Pages 930-936

  Yang, Bo ^a,b   Meng, Zhiyun ^a   Dong, Junxing ^b   Yan, Liangping ^c   Zou, Libo ^c   Tang, Zhongming ^b   Dou, Guifang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYNARINE; GLUCURONOSYLTRANSFERASE; MICROSOME ENZYME;

ARTICLE; BILE; CATALYSIS; CELL LINE; COMPARATIVE STUDY; CORRELATION ANALYSIS; CYTOSOL; DRUG METABOLISM; GLUCURONIDATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LIVER; MALE; METABOLITE; METHYLATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; URINE; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; CINNAMATES; MALE; RATS; RATS, WISTAR;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 22344444115     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002154     Document Type: Article

References (22)

1. Choudhury R, Srai SK, Debnam E, and Rice-Evans CA (1999) Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic Biol Med 27:278-286.
2. Crespy V, Morand C, Manach C, Besson C, Demigne C, and Remesy C (1999) Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 277:G120-G126.
3. Filip R and Ferraro GE (2003) Researching on new species of "Mate": Ilex brevicuspis: phytochemical and pharmacology study. Eur J Nutr 42:50-54.
4. Fraisse D, Carnat A, Carnat AP, Guedon D, and Lamaison JL (2003) [Hydroxycinnamic acid levels of various batches from mugwort flowering tops] (French). Ann Pharm Fr 61:265-268.
5. Gonthier MP, Verny MA, Besson C, Rémésy C, and Scalbert A (2003) Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 133:1853-1859.
6. King PJ, Ma G, Miao W, Jia Q, McDougall BR, Reinecke MG, Cornell C, Kuan J, Kim TR, and Robinson WE Jr (1999) Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. J Med Chem 42:497-509.
7. McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG, and Robinson WE Jr (1998) Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob Agents Chemother 42:140-146.
8. Moreira RF, Trugo LC, de Maria CA, Matos AG, Santos SM, and Leite JM (2001) Discrimination of Brazilian arabica green coffee samples by chlorogenic acid composition. Arch Latinoam Nutr 51:95-99.
9. Olthof MR, Hollman PCH, Buijsman MNCP, Amelsvoort JMMV, and Katan MB (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133:1806-1814.
10. Olthof MR, Hollman PCH, and Katan MB (2001) Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131:66-71.
11. Parejo I, Viladomat F, Bastida J, and Codina C (2004) Development and validation of a high-performance liquid chromatographic method for the analysis of antioxidative phenolic compounds in fennel using a narrow bore reversed phase C18 column. Anal Chim Acta 512:271-280.
12. Robinson WE Jr (1998) L-Chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG 1350). Antiviral Res 39:101-111.
13. Robinson WE Jr, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG, and Mitchell WM (1996a) Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol Pharmacol 50:846-855.
14. Robinson WE Jr, Reinecke MG, Abdel-Malek S, Jia Q, and Chow SA (1996b) Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase. Proc Natl Acad Sci USA 93:6326-6331.
15. Singh A, Naidu PS, and Kulkarni SK (2003) Quercetin potentiates L-dopa reversal of druginduced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology 68:81-88.
16. Slanina J, Táborská E, Bochořáková H, Slaninová I, Humpa O, Robinson WE Jr, and Schram KH (2001) New and facile method of preparation of the anti-HIV-1 agent, 1,3-dicaffeoylquinic acid. Tetrahedron Lett 42:3383-3385.
17. Takenaka M, Nagata T, and Yoshida M (2000) Stability and bioavailability of antioxidants in garland (Chrysanthemum coronarium L.). Biosci Biotechnol Biochem 64:2689-2691.
18. Tolonen A, Joutsamo T, Mattlla S, Kamarainen T, and Jalonen J (2002) Identification of isomeric dicaffeoylquinic acids from Eleutherococcus senticosus using HPLC-ESI/TOF/MS and 1HNMR methods. Phytochem Anal 13:316-328.
19. Um BH, Polat M, Lobstein A, Weniger B, Aragon R, Declercq L, and Anton R (2002) A new dicaffeoylquinic acid butyl ester from Isertia pittieri. Fitoterapia 73:550-552.
20. Yoshimoto M, Yahara S, Okuno S, Islam MS, Ishiguro K, and Yamakawa O (2002) Antimutagenicity of mono-, di- and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci Biotechnol Biochem 66:2336-2341.
21. Zhu BT, Patel UK, Cai MX, and Conney AH (2000) O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab Dispos 28:1024-1030.
22. Zhu K, Cordeiro ML, Atienza J, Robinson WE Jr, and Chow SA (1999) Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids. J Virol 73: 3309-3316.